Abstract
Research in extending medical isotopes for the diagnosis and treatment of numerous health maladies is hampered by outages and upsets in major supply sources. Investigations in cures for brain cancer (211At), HIV/AIDS virus (213Bi), and even bacterial vectors are either in reduced progress mode or have been cancelled until isotopes become available. Examples of several key radioactive medical isotopes include 99mTc for diagnostics, 131I for non-Hodgkin’s lymphoma and thyroid cancer, 225Ac for acute myelogenous leukemia, and 67Cu for lymphoma cancer. Possibilities for developing commercially viable sources using compact accelerators and next generation research and production reactors are discussed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
